We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

117 hedge funds and large institutions have $833M invested in Mirum Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

12,221% more call options, than puts

Call options by funds: $10.3M | Put options by funds: $84K

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

38% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 29

28% more capital invested

Capital invested by funds: $650M → $833M (+$183M)

13% more funds holding

Funds holding: 104 → 117 (+13)

0.95% more ownership

Funds ownership: 90.42% → 91.37% (+0.95%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
117
Holders Change
+13
Holders Change %
+12.5%
% of All Funds
1.86%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
24
Increased
40
Reduced
29
Closed
11
Calls
$10.3M
Puts
$84K
Net Calls
+$10.3M
Net Calls Change
+$9.98M

Top Buyers

1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$18.3M
2
PA
Perceptive Advisors
New York
+$13.7M
3
CCM
Cadian Capital Management
New York
+$8.15M
4
PM
Prosight Management
Texas
+$5.9M
5
SCM
Soleus Capital Management
Connecticut
+$5.52M

Top Sellers

1
State Street
State Street
Massachusetts
-$13.4M
2
BlackRock
BlackRock
New York
-$9.73M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$3.41M
4
Citigroup
Citigroup
New York
-$2.24M
5
SCM
Stonepine Capital Management
Oregon
-$2.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$101M – – –
FLSM
2
Frazier Life Sciences Management
California
$92.7M – – –
EAM
3
Eventide Asset Management
Massachusetts
$49.5M +$50.2K +2,201 +0.1%
DM
4
Deerfield Management
New York
$48.8M – – –
RSCM
5
Rock Springs Capital Management
Maryland
$43.1M – – –
BlackRock
6
BlackRock
New York
$41.1M -$9.73M -426,851 -20%
NHAS
7
Novo Holdings A/S
Denmark
$40.5M – – –
RVM
8
RiverVest Venture Management
Missouri
$38.9M – – –
Citadel Advisors
9
Citadel Advisors
Florida
$32.9M -$894K -39,214 -3%
Vanguard Group
10
Vanguard Group
Pennsylvania
$30.6M +$263K +11,529 +0.9%
State Street
11
State Street
Massachusetts
$28.1M -$13.4M -588,193 -33%
TCM
12
Tang Capital Management
California
$28.1M +$1.14M +50,000 +4%
PCH
13
Polar Capital Holdings
United Kingdom
$22.3M +$1.71M +75,000 +9%
Axa
14
Axa
France
$21.3M -$1.32M -57,984 -6%
PAMS
15
Pictet Asset Management (Switzerland)
Switzerland
$19.3M +$18.3M +804,129 New
CCM
16
Cadian Capital Management
New York
$17.7M +$8.15M +357,548 +95%
PA
17
Perceptive Advisors
New York
$14.4M +$13.7M +601,566 New
PM
18
Prosight Management
Texas
$13.6M +$5.9M +259,050 +84%
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$13.4M +$4.97M +217,928 +64%
WP
20
Woodline Partners
California
$12.6M +$3.72M +163,288 +45%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$10M +$422K +18,532 +5%
Franklin Resources
22
Franklin Resources
California
$9.62M +$456 +20 +0%
Goldman Sachs
23
Goldman Sachs
New York
$9.42M -$1.13M -49,403 -11%
Barclays
24
Barclays
United Kingdom
$7.19M -$1.78M -78,109 -21%
SCM
25
Soleus Capital Management
Connecticut
$5.81M +$5.52M +242,000 New
1
2 3 4 5

MIRM Hedge Fund Activity: Q1 2023 in Review

117 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q1 2023, worth a combined $833M — up 28% from $650M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new MIRM positions and 11 closed out — a net gain of 13 holders — while 40 added to existing stakes and 29 trimmed.

The largest buyer was Pictet Asset Management (Switzerland), opening a new position worth an estimated $18.3M. The largest seller was State Street, cutting an estimated $13.4M.

  • 117 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q1 2023, up from 104 in Q4 2022.
  • Funds reported $833M of Mirum Pharmaceuticals stock for Q1 2023, up 28% quarter-over-quarter.
  • 24 funds opened new Mirum Pharmaceuticals positions in Q1 2023 and 11 closed out, a net change of +13 holders.
  • The largest Mirum Pharmaceuticals buyer in Q1 2023 was Pictet Asset Management (Switzerland), an estimated $18.3M added.
  • The largest Mirum Pharmaceuticals seller in Q1 2023 was State Street, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2023.